|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-6-2
|
|
pubmed:abstractText |
To compare the efficacy and toxicities of irinotecan/ platinum (IP) with etoposide/platinum (EP) in patients with previously untreated extensive-stage small cell lung cancer (E-SCLC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
867-73
|
|
pubmed:dateRevised |
2011-2-11
|
|
pubmed:meshHeading |
pubmed-meshheading:20521354-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20521354-Camptothecin,
pubmed-meshheading:20521354-Carboplatin,
pubmed-meshheading:20521354-Carcinoma, Small Cell,
pubmed-meshheading:20521354-Cisplatin,
pubmed-meshheading:20521354-Disease-Free Survival,
pubmed-meshheading:20521354-Etoposide,
pubmed-meshheading:20521354-Humans,
pubmed-meshheading:20521354-Lung Neoplasms,
pubmed-meshheading:20521354-Randomized Controlled Trials as Topic
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.
|
|
pubmed:affiliation |
Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
